Other possibilities,
Ajanta, Cipla, Ipca, Guilin, Novartis, Sanofi-aventis 80% drop in factory gate malaria medicine prices in 2010 impacted after EMS original outlook and before Suda.
TGA process required buyer/funder/adviser.
Vaccine needs longer trials and children have lower immunity.
https://www.theglobalfund.org/en/ne...-prices-of-malaria-medicines-by-up-to-80-pct/
Other possibilities, Ajanta, Cipla, Ipca, Guilin, Novartis,...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 14.0¢ | $212.8K | 1.496M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 435513 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 9923 | 1 |
View Market Depth
| Last trade - 15.45pm 06/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |